Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

682 evidence items · page 27 / 28

22.12 score_unitsThe mean SCD knowledge of participants in the study was 22.12 ± 2.76.

Nigeriadrépanocytosepublished 2020The Pan African medical journalPubMeddocument of 8 observations

1,609 patientsSouth West registered 1,609 patients with sickle cell disease, representing 20.7% of the total enrolled in Nigeria.

Nigeriadrépanocytosepublished 2022Frontiers in geneticseurope_pmcdocument of 8 observations

1.4 %1.4% of the children with sickle cell anaemia had low free T3.

Nigeriadrépanocytose · hypothyroidismpublished 2023Ethiopian journal of health sciencesPubMeddocument of 7 observations

7.7 yearsThe mean age of the 130 children with sickle cell anaemia in the study was 7.7 years with a standard deviation of 4.1 years.

Nigeriadrépanocytosepublished 2021West African journal of medicinePubMeddocument of 5 observations

97.5 %Among 3622 enrolled sickle cell disease patients in Nigeria, the frequency of Hb SS was 97.5%.

Nigeriadrépanocytose · Hb SSpublished 2020Blood cells, molecules & diseaseseurope_pmcdocument of 16 observations

11.2 odds_ratioChildren admitted for Sickle cell disease had an odds ratio of 11.2 for prolonged hospital stay (>72 hours) at the Children Emergency Room of the University of Calabar Teaching Hospital in Nigeria in 2014.

Nigeriadrépanocytoseobserved 2014published 2019African health sciencesPubMeddocument of 7 observations

239 womenIn a randomized controlled trial in southwest Nigeria, 239 pregnant women with HbSS or HbSC received 100 mg aspirin daily.

Nigeriadrépanocytosepublished 2026The Lancet. Global healthPubMeddocument of 13 observations

4.5 %Among 308 children with sickle cell disease in Nigeria, cerebral artery blood velocity was high in 14 (4.5%).

Nigeriadrépanocytosepublished 2023Archives of disease in childhoodPubMeddocument of 5 observations

42.4 %The prevalence of myocardial ischemia measuring cardiac troponin T alone in children with sickle cell anemia during vaso-occlusive crisis was 42.4%.

Nigeriadrépanocytose · myocardial ischemiaobserved 2019published 2024Journal of tropical pediatricsPubMeddocument of 6 observations

8 %Folate deficiency was observed in eight percent of the subjects and none of the controls.

Nigeriadrépanocytoseobserved between September 2018 and March 2019published 2021African health sciencesPubMeddocument of 3 observations

41.1 %Among the participants who were incorrect about their haemoglobin "genotype", 41.1% (23/56) of women who reported their haemoglobin "genotype" as AA were actually AS.

Nigeriadrépanocytose · trait drépanocytairepublished 2021BMC pregnancy and childbirtheurope_pmcdocument of 4 observationsDOI 10.1186/s12884-021-03974-4

7.8 %The median percentage foetal haemoglobin increased from 7.8% to 14% after 12 months of hydroxyurea therapy.

Nigeriadrépanocytosepublished 2020Journal of tropical pediatricsPubMeddocument of 4 observations

86 %For HbAS phenotype, isoelectric focusing showed a specificity of 86%.

Nigeriadrépanocytosepublished 2022Frontiers in geneticseurope_pmcdocument of 23 observations

71 %At the 30% threshold, 71% of the poorest quartile of sickle cell disease patients experienced catastrophic expenditure.

Nigeriadrépanocytosepublished 2022PloS onePubMeddocument of 5 observations

271.1 µmThe SCD group had lower mean macular thickness (MMT) of 271.1 ± 20.2 µm compared to non-SCD group with MMT of 278.5 ± 13.5 µm.

Nigeriadrépanocytosepublished 2025The Nigerian postgraduate medical journalPubMeddocument of 6 observations

69.6 %CYP2C19 *1/*1 genotype frequency was 69.6% in the SCD group.

Nigeriadrépanocytosepublished 2010Journal of clinical pharmacy and therapeuticseurope_pmcdocument of 10 observations

8.6 %The prevalence of chronic kidney disease from stages 3–5 using estimated glomerular filtration rate was 8.6% among patients with sickle cell disease in Ahmadu Bello University Teaching Hospital, Zaria.

NigeriadrépanocytosePubMeddocument of 7 observations

150,000 births_per_yearSickle cell disease affects about 150,000 births annually in Nigeria.

Nigeriadrépanocytosepublished 2017Hemoglobineurope_pmcdocument of 5 observations

Sickle cell disease is the most common genetic disorder in sub-Saharan Africa.

Nigeriadrépanocytosepublished 2025Annals of African medicinePubMeddocument of 12 observations

37.8 %Among 135 physicians caring for SCD patients in a southwestern state of Nigeria, 51 (37.8%) would recommend prenatal SCD diagnosis.

Nigeriadrépanocytosepublished 2020TheScientificWorldJournalPubMeddocument of 9 observations

50 %Nearly 50% of the participants with sickle cell disease-related priapism had never sought medical attention for this complication.

Nigeriadrépanocytosepublished 2020Blood advancesPubMeddocument of 5 observations

0.5 correlation_coefficientThere was a statistically significant positive correlation between BMI and LV mass among the subjects (n = 50, r = 0.5, P < 0.001).

Nigeriadrépanocytosepublished 2021Nigerian journal of clinical practicePubMeddocument of 3 observations

0 %Among 3622 enrolled sickle cell disease patients in Nigeria, the frequency of Hb Sβ thalassemia was 0%.

Nigeriadrépanocytose · Hb Sβ thalassemiapublished 2020Blood cells, molecules & diseaseseurope_pmcdocument of 16 observations

7.5 %Six SCD participants (7.5%) tested positive for atypical erythrocyte alloantibodies.

Nigeriadrépanocytosepublished 2021ImmunohematologyPubMeddocument of 7 observations

28.9 %Left ventricular hypertrophy was observed in 13 out of 45 (28.9%) pediatric sickle cell anaemia patients in steady state.

Nigeriadrépanocytoseobserved 2023published 2025BMC pediatricsPubMeddocument of 16 observations

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.